• Home
  • Latest
  • Coins2Day 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

Page 56 of 100
Jury Deliberations Continue In Martin Shkreli Securities Fraud Trial
Tech‘Pharma Bro’ Martin Shkreli Heads to Jail For Placing Bounty on Hillary Clinton’s Hair
By ReutersSeptember 13, 2017
Key Speakers At 16th Nikkei Global Management Forum 2014
HealthStruggling Israeli Generics Maker Teva Finally Names New CEO
By Natasha BachSeptember 11, 2017
CNBC Events
HealthBotox Maker Allergan’s CEO Defends Selling Drug Patents to Native American Tribe to Thwart Rivals
By Sy MukherjeeSeptember 9, 2017
Former Turing Pharmaceuticals CEO Martin Shkreli On Trial For Securities Fraud
LeadershipProsecutors Want Martin Shkreli Jailed After Hillary Clinton Hair ‘Threat’
By Lucinda ShenSeptember 8, 2017
Businessman with Duchenne muscular dystrophy in a motorized wheelchair working in an office
HealthThis Controversial Biotech May Yet Defy Its Skeptics
By Sy MukherjeeSeptember 6, 2017
Novartis CEO Joe Jimenez Interview and Tour of $1 Billion Research Center
HealthNovartis CEO Joseph Jimenez Is Stepping Down
By David MeyerSeptember 4, 2017
HealthIs $475,000 Too High a Price for Novartis’s ‘Historic’ Cancer Gene Therapy?
By Sy MukherjeeAugust 31, 2017
Novartis CEO Joe Jimenez Interview and Tour of $1 Billion Research Center
HealthThe Way We Treat Cancer Will Be Revolutionized As Gene Therapy Comes to the U.S.
By Sy MukherjeeAugust 30, 2017
Elijah Cummings, Peter Welch
HealthHouse Democrats Start Multiple Sclerosis Drug Price Probe
By BloombergAugust 17, 2017
Fosun International Ltd. Chairman And Billionaire Guo Guangchang Attends Interim Results News Conference
FinanceChina’s Fosun Is Defying Beijing’s Crackdown on Debt and Foreign M&A
By Coins2Day Editors and ReutersAugust 14, 2017
Forbes Under 30 Summit
HealthWhy SoftBank Made a Record-Breaking $1.1 Billion Bet on This Biotech Firm
By Sy MukherjeeAugust 9, 2017
CommentaryWhy Martin Shkreli Won’t Be the Last Pharma Bro
By Josh HoxieAugust 8, 2017
Hepatitis C drug can cure, if patients can get it
HealthThe FDA Just Approved the First Drug That Can Treat All Hepatitis C Strains in Just 8 Weeks
By Sy MukherjeeAugust 3, 2017
Inside Teva Pharmaceuticals Headquarters
FinancePharma Giant Teva’s Stock Is Imploding As Generic Drugs Get Cheaper
By BloombergAugust 3, 2017
Jury Deliberations Continue In Martin Shkreli Securities Fraud Trial
FinanceJury in Martin Shkreli Trial Asks the Judge to Define ‘Fraudulent Intent’
By ReutersAugust 1, 2017
1...
  • 54
  • 55
  • 56
  • 57
  • 58
...100
Most Popular
Success
In 2026, many employers are ditching merit-based pay bumps in favor of ‘peanut butter raises’An image of a popular article
By Emma BurleighFebruary 2, 2026
Cybersecurity
Top AI leaders are begging people not to use Moltbook, a social media platform for AI agents: It’s a ‘disaster waiting to happen’An image of a popular article
By Eva RoytburgFebruary 2, 2026
Investing
Tech stocks go into free fall as it dawns on traders that AI has the ability to cut revenues across the boardAn image of a popular article
By Jim EdwardsFebruary 4, 2026
Rankings
  • 100 Best Companies
  • Coins2Day 500
  • Global 500
  • Coins2Day 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Coins2Day Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Coins2Day Brand Studio
  • Coins2Day Analytics
  • Coins2Day Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Coins2Day
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Coins2Day Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Coins2Day Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.